Andere talen GB Sciences, Inc.

Aandelen

GBLX

US3615441090

Beurs gesloten - OTC Markets Andere beurzen 19:44:16 28-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,011 ^USD	-6,78%		-12,00%	+71,88%

12/02	GB Sciences, Inc. rapporteert resultaten voor het derde kwartaal en de negen maanden eindigend op 31 december 2023	CI
2023	GB Sciences, Inc. rapporteert resultaten voor het tweede kwartaal en de zes maanden eindigend op 30 september 2023	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

GB Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	12/02
GB Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	20/11
GB Sciences, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	14-08-23
GB Sciences, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	14-07-23
GB Sciences, Inc. Auditor Raises 'Going Concern' Doubt	14-07-23
Gb Sciences' First-In-Class Parkinson's Disease Therapy Successfully Completes Dose Response Study At the University of Lethbridge	11-07-23
GB Sciences, Inc. announced a financing transaction	30-06-23
GB SCIENCES INC : Change in Directors or Principal Officers (form 8-K)	14-04-23
GB Sciences, Inc. Announces Executive Changes	14-04-23
GB SCIENCES INC : Submission of Matters to a Vote of Security Holders (form 8-K)	10-03-23
GB SCIENCES INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	03-02-23
GB Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	03-02-23
Gb Sciences Identifies Novel Cannabis-Inspired Mixtures as Anti-Inflammatory Therapies Based on Proprietary AI-Enabled Drug Discovery Platform	22-12-22
Gb Sciences Identifies Novel Cannabis-Inspired Mixtures as Anti-Inflammatory Therapies Based on Proprietary AI-Enabled Drug Discovery Platform	22-12-22
Gb Sciences Addresses Growing Need for Anxiety and Depression Medications With Non-Psychedelic, Kava-Based Formulations	12-12-22
Gb Sciences Addresses Growing Need for Anxiety and Depression Medications With Non-Psychedelic, Kava-Based Formulations	12-12-22
GB SCIENCES INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	09-11-22
GB Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	09-11-22
Gb Sciences Co-Publishes Study Demonstrating Anti-Inflammatory Properties of Cannabis Ingredients	01-11-22
TODAY: Gb Sciences' President Demonstrates Benefits of AI-Enabled Drug Discovery Engine for Novel Plant-Inspired Pharmaceuticals at 10th Annual Drug Discovery Strategic Summit	27-10-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen GB Sciences, Inc.

Aandelen

GBLX

US3615441090

Andere talen

Filters